Drugs Info Brought Closer To Patients Via The Internet

16 June 1996

Direct contact between drug-consumers and the pharmaceutical industry is forecast by Edward Roberts, head of the pharmaceutical division of German drugmaker E Merck of Darmstadt and chairman of Pharmaceutical Partners for Better Healthcare. He cited a recent conference on cancer in Philadelphia, USA, where results of a Merck research-based drug study were presented on the Internet two days later.

Mr Roberts said this meant that patients visiting this Internet site already knew more about the product two days later than did 99.9% of Merck's own work colleagues. He added that the technology would lead to an explosion in generally available drug data, with the drug industry in future facing better-informed patients.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight